Literature DB >> 7696849

Expression of galectins on microvessel endothelial cells and their involvement in tumour cell adhesion.

R Lotan1, P N Belloni, R J Tressler, D Lotan, X C Xu, G L Nicolson.   

Abstract

Lactoside-binding lectins (galectins) with molecular weights of about 14.5 kDa (galectin-1) and 29-35 kDa (galectin-3) bind preferentially to polylactosaminoglycan-containing glycoconjugates and have been found on the surface of tumour cells and implicated in cell-cell and cell-extracellular matrix adhesion and metastasis. We have demonstrated by immunoblotting that both galectin-1 and galectin-3 are present in extracts of endothelial cells cultured from bovine aorta, rat lung, mouse lung and mouse brain microvessels, whereas mouse hepatic sinusoidal endothelial cells expressed primarily galectin-1. These galectins were also localized by indirect immunofluorescent labelling on the surface of the different endothelial cells in culture and by immunohistochemical staining in human tissues in vivo. Anti-galectin-1 antibodies inhibited the adhesion of liver-preferring murine RAW117-H10 large-cell lymphoma cells to hepatic sinusoidal endothelial cells or lung microvessel endothelial cells in vitro. The data indicate that galectin-1 is expressed on the extracellular surface of endothelial cells and can mediate in part the adhesion of RAW117-H10 cells to liver microvessel endothelial cells.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7696849     DOI: 10.1007/bf00731282

Source DB:  PubMed          Journal:  Glycoconj J        ISSN: 0282-0080            Impact factor:   2.916


  49 in total

Review 1.  Cell adhesion in invasion and metastasis.

Authors:  J Behrens; U Frixen; J Schipper; M Weidner; W Birchmeier
Journal:  Semin Cell Biol       Date:  1992-06

Review 2.  Microvascular endothelial cell heterogeneity: interactions with leukocytes and tumor cells.

Authors:  P N Belloni; R J Tressler
Journal:  Cancer Metastasis Rev       Date:  1990-02       Impact factor: 9.264

3.  Differential expression of cell surface glycoproteins on various organ-derived microvascular endothelia and endothelial cell cultures.

Authors:  P N Belloni; G L Nicolson
Journal:  J Cell Physiol       Date:  1988-09       Impact factor: 6.384

Review 4.  Endogenous lectins as mediators of tumor cell adhesion.

Authors:  R Lotan; A Raz
Journal:  J Cell Biochem       Date:  1988-05       Impact factor: 4.429

5.  Selection and biologic properties of malignant variants of a murine lymphosarcoma.

Authors:  K W Brunson; G L Nicolson
Journal:  J Natl Cancer Inst       Date:  1978-12       Impact factor: 13.506

6.  In vivo and in vitro properties of malignant variants of RAW117 metastatic murine lymphoma/lymphosarcoma.

Authors:  C L Reading; P M Kraemer; K M Miner; G L Nicolson
Journal:  Clin Exp Metastasis       Date:  1983 Apr-Jun       Impact factor: 5.150

7.  L-14 lectin recognition of laminin and its promotion of in vitro cell adhesion.

Authors:  Q Zhou; R D Cummings
Journal:  Arch Biochem Biophys       Date:  1993-01       Impact factor: 4.013

8.  Modification of blood-borne arrest properties of lymphoma cells by inhibitors of protein glycosylation suggests the existence of endogenous lectins.

Authors:  N Schaaf-Lafontaine; R J Hooghe; F Vander Plaetse
Journal:  Carbohydr Res       Date:  1985-05-15       Impact factor: 2.104

Review 9.  Cell surface carbohydrates in cell adhesion.

Authors:  B K Brandley
Journal:  Semin Cell Biol       Date:  1991-10

10.  Localization of endogenous beta-galactoside-binding lectin in human cells and tissues.

Authors:  H J Allen; D Sucato; S Gottstine; E Kisailus; H Nava; N Petrelli; N Castillo; D Wilson
Journal:  Tumour Biol       Date:  1991
View more
  34 in total

1.  The galectin profile of the endothelium: altered expression and localization in activated and tumor endothelial cells.

Authors:  Victor L Thijssen; Sarah Hulsmans; Arjan W Griffioen
Journal:  Am J Pathol       Date:  2008-01-17       Impact factor: 4.307

2.  Characteristics of virus-specific CD8(+) T cells in the liver during the control and resolution phases of influenza pneumonia.

Authors:  G T Belz; J D Altman; P C Doherty
Journal:  Proc Natl Acad Sci U S A       Date:  1998-11-10       Impact factor: 11.205

Review 3.  Galectins as therapeutic targets for hematological malignancies: a hopeful sweetness.

Authors:  Camilo Pena; Leonardo Mirandola; Jose A Figueroa; Nattamol Hosiriluck; Natallia Suvorava; Kayley Trotter; Adair Reidy; Rahman Rakhshanda; Drew Payne; Marjorie Jenkins; Fabio Grizzi; Lauren Littlefield; Maurizio Chiriva-Internati; Everardo Cobos
Journal:  Ann Transl Med       Date:  2014-09

4.  Galectin-1 is essential in tumor angiogenesis and is a target for antiangiogenesis therapy.

Authors:  Victor L J L Thijssen; Ruben Postel; Ricardo J M G E Brandwijk; Ruud P M Dings; Irina Nesmelova; Sietske Satijn; Nicole Verhofstad; Yusaku Nakabeppu; Linda G Baum; Jeroen Bakkers; Kevin H Mayo; Françoise Poirier; Arjan W Griffioen
Journal:  Proc Natl Acad Sci U S A       Date:  2006-10-16       Impact factor: 11.205

Review 5.  Galectins in tumor angiogenesis.

Authors:  Arjan W Griffioen; Victor L Thijssen
Journal:  Ann Transl Med       Date:  2014-09

6.  Haploinsufficiency of C2GnT-I glycosyltransferase renders T lymphoma cells resistant to cell death.

Authors:  Paula V Cabrera; Maho Amano; Junya Mitoma; Jessica Chan; Jonathan Said; Minoru Fukuda; Linda G Baum
Journal:  Blood       Date:  2006-06-15       Impact factor: 22.113

7.  Galectin-3: a potential target for cancer prevention.

Authors:  Hafiz Ahmed; Prasun Guha; Engin Kaptan; Gargi Bandyopadhyaya
Journal:  Trends Carbohydr Res       Date:  2011

8.  Galectin-3 reduces the severity of pneumococcal pneumonia by augmenting neutrophil function.

Authors:  Sarah L Farnworth; Neil C Henderson; Alison C Mackinnon; Kirsten M Atkinson; Tom Wilkinson; Kevin Dhaliwal; Katsutoshi Hayashi; A John Simpson; Adriano G Rossi; Christopher Haslett; Tariq Sethi
Journal:  Am J Pathol       Date:  2008-01-17       Impact factor: 4.307

9.  Extravasation of leukocytes in comparison to tumor cells.

Authors:  Carina Strell; Frank Entschladen
Journal:  Cell Commun Signal       Date:  2008-12-04       Impact factor: 5.712

10.  A novel biological activity for galectin-1: inhibition of leukocyte-endothelial cell interactions in experimental inflammation.

Authors:  Mylinh La; Thong V Cao; Graziela Cerchiaro; Kathya Chilton; Jun Hirabayashi; Ken-Ichi Kasai; Sonia M Oliani; Yuti Chernajovsky; Mauro Perretti
Journal:  Am J Pathol       Date:  2003-10       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.